Valuation (14%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -4.24 | 31.19 |
| PEG Ratio (TTM) | -0.19 | 10.58 |
| P/S Ratio (TTM) | N/A | 5.89 |
| P/B Ratio (TTM) | 0.61 | 4.60 |
| P/FCF Ratio (TTM) | -1.12 | 19.05 |
| Price to 5YR AVG Earnings Ratio | N/A | 29.89 |
| Price to 5YR AVG FCF Ratio | N/A | 41.81 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -11.63% | 6.21% |
| ROE (TTM) | -35.68% | 11.71% |
| Net Profit Margin (TTM) | N/A | 14.31% |
| ROIC 5YR AVG | N/A | 18.98% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -30.00% | -106.16% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -53.98% | 516.84% | N/A |
| Cash Flow | -18.01% | -1,303.66% | N/A |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.81 | 3.60 |
| Quick Ratio (TTM) | 3.77 | 3.07 |
| D/E Ratio (TTM) | 0.06 | 1.24 |
| Interest Coverage (TTM) | -1,100.06 | 1.58 |
| Piotroski F-Score | 1 | 6 |
| Altman Z-Score | N/A | 17.78 |
| LTL to 5YR AVG FCF | N/A | 1.34 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.45% |